Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EV/Net Sales

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EV/Net Sales History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   EV/Net Sales(x) -0.030.06-0.07-0.040.03

What is the latest EV/Net Sales ratio of MANKIND PHARMA ?

The latest EV/Net Sales ratio of MANKIND PHARMA is -0.03 based on Mar2023 Consolidated results.
Year EV/Net Sales
Mar2023-0.03
Mar20220.06
Mar2021-0.07
Mar2020-0.04
Mar20190.03

How is EV/Net Sales of MANKIND PHARMA Trending?

Years EV/Net Sales % Change
Mar2023 -0.03
Negative
Mar2022 0.06
Positive
Mar2021 -0.07
Negative
Mar2020 -0.04
Negative
Mar2019 0.03 -

Other Financial Ratios of MANKIND PHARMA


Compare EV/Net Sales ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹84,588.7 Cr -6.1% -11.9% 54.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,290.0 Cr -0.9% 0.9% 62.6% Stock Analytics
CIPLA ₹113,357.0 Cr 3.5% 4.2% 51.8% Stock Analytics
ZYDUS LIFESCIENCES ₹111,134.0 Cr 12.2% 18% 103.8% Stock Analytics
DIVIS LABORATORIES ₹104,235.0 Cr 0.8% 5.6% 19.3% Stock Analytics
DR REDDYS LABORATORIES ₹97,001.5 Cr -1% -2.4% 28.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-6.1%

-11.9%

54.1%

SENSEX

1.7%

1.5%

18.7%


You may also like the below Video Courses